Giana Berleze Penna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Giana Berleze Penna has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Tassiana Costa da Silva
Federal University of Rio Grande do Sul
3 shared publicationsAnderson Sartor Pedroni
Universidade Federal de Ciências da Saúde de Porto Alegre
2 shared publications- Bruna Kuhn
Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil
2 shared publications Bruna Ziegler
Federal University of Rio Grande do Sul
2 shared publicationsFabricio Edler Macagnan
Universidade Federal de Ciências da Saúde de Porto Alegre
2 shared publications- Fabrício Edler Macagnan
Universidade Federal de Ciências da Saúde de Porto Alegre
2 shared publications
Latest Publications
- 13 March 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (4) , 1-6
Impact of functional capacity before hematopoietic stem cell transplantation on the length of hospital stay
Objective To verify the association between pre-HSCT functional capacity and the variables of pulmonary function, fatigue, and length of hospital stay. Methods This is a cohort study, involving patients admitted to the bone marrow transplantation. The individuals were submitted to an evaluation in the first 24 h of hospitalization. The length of stay variable was checked on the day of hospital discharge. Functional capacity was assessed through the six-minute walk test (6MWT), and the 30-second sit-to-stand test (SST30) was performed to assess the indirect strength of the lower limbs; moreover, the revised Piper Fatigue Scale was used for the evaluation of the pulmonary function. Results The sample consisted of 35 individuals (19 male; 54%). Fourteen patients achieved a 6MWT ≥80% predicted. The mean age of the sample was 45.5 ± 15.2 years, and BMI 27.4 ± 5.4 kg/m2. Patients who completed a six-minute walking distance (6MWD) below the predicted value showed significantly lower pulmonary function values for the variables peak expiratory flow (PEF) (%) (p = 0.031), forced expiratory volume in one second (FEV1) (%) (p = 0.033), and FEV1/forced vital capacity (FVC) (%) (p = 0.027) in relation to the group with better functional capacity. This group showed significantly higher values in the assessment of lower limb fatigue using the Borg scale pre- (p = 0.008) and post- (p = 0.004) 6MWT, longer hospitalization time (p = 0.0014), but with no significant difference in lower limb muscle strength between groups (p = 0.21). A moderate correlation was found between the 6MWD% and FEV1% (p < 0.05). Conclusion Data indicate that starting HSCT treatment with lower-than-expected physical fitness is associated with lower lung function, greater fatigue in the lower limbs, and longer hospital stays.
- 13 March 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (4) , 1-6
Impact of functional capacity before hematopoietic stem cell transplantation on the length of hospital stay
Objective To verify the association between pre-HSCT functional capacity and the variables of pulmonary function, fatigue, and length of hospital stay. Methods This is a cohort study, involving patients admitted to the bone marrow transplantation. The individuals were submitted to an evaluation in the first 24 h of hospitalization. The length of stay variable was checked on the day of hospital discharge. Functional capacity was assessed through the six-minute walk test (6MWT), and the 30-second sit-to-stand test (SST30) was performed to assess the indirect strength of the lower limbs; moreover, the revised Piper Fatigue Scale was used for the evaluation of the pulmonary function. Results The sample consisted of 35 individuals (19 male; 54%). Fourteen patients achieved a 6MWT ≥80% predicted. The mean age of the sample was 45.5 ± 15.2 years, and BMI 27.4 ± 5.4 kg/m2. Patients who completed a six-minute walking distance (6MWD) below the predicted value showed significantly lower pulmonary function values for the variables peak expiratory flow (PEF) (%) (p = 0.031), forced expiratory volume in one second (FEV1) (%) (p = 0.033), and FEV1/forced vital capacity (FVC) (%) (p = 0.027) in relation to the group with better functional capacity. This group showed significantly higher values in the assessment of lower limb fatigue using the Borg scale pre- (p = 0.008) and post- (p = 0.004) 6MWT, longer hospitalization time (p = 0.0014), but with no significant difference in lower limb muscle strength between groups (p = 0.21). A moderate correlation was found between the 6MWD% and FEV1% (p < 0.05). Conclusion Data indicate that starting HSCT treatment with lower-than-expected physical fitness is associated with lower lung function, greater fatigue in the lower limbs, and longer hospital stays.
- Open Access
- 4 December 2023
- Published by Springer Nature in Research Square
Impact of functional capacity before hematopoietic stem cell transplantation on the length of hospital stay
Objective: To verify the association between pre-HSCT functional capacity and the variables of pulmonary function, fatigue and length of hospital stay. Methods: This is a cohort study, involving patients admitted to the Bone Marrow Transplantation. The individuals were submitted to an evaluation in the first 24 hours of hospitalization. The length of stay variable was checked on the day of hospital discharge. Functional capacity was assessed through the 6MWT, the 30-second sit-to-stand test (TSL30) was performed to assess the indirect strength of the lower limbs, moreover was used Revised Piper Fatigue Scale and evaluation of the pulmonary function. Results: The sample consisted of thirty-five individuals (19 male; 54%). Fourteen patients achieved a 6MWT ≥80% predicted. The mean age of the sample was 45.5 ± 15.2 years, and BMI 27.4 ± 5.4 kg/m². Patients who completed a 6MWD below the predicted value showed significantly lower pulmonary function values for the variables PEF(%) (p=0.031), FEV1 (%) (p=0.033) and FEV1/FVC(%) (p=0.027) in relation to the group with better functional capacity. This group showed significantly higher values in the assessment of lower limb fatigue using the Borg scale pre (p=0.008) and post (p=0.004) 6MWT, longer hospitalization time (p=0.0014), but with no significant difference in lower limb muscle strength between groups (p=0.21). A moderate correlation was found between the 6MWD% and FEV1% (p<0.05). Conclusion: Data indicate that starting HSCT treatment with lower-than-expected physical fitness is associated with lower lung function, greater fatigue in the lower limbs, and longer hospital stays.
- 4 December 2023
- Published by Springer Nature in Research Square
Open AccessImpact of functional capacity before hematopoietic stem cell transplantation on the length of hospital stay
Objective: To verify the association between pre-HSCT functional capacity and the variables of pulmonary function, fatigue and length of hospital stay. Methods: This is a cohort study, involving patients admitted to the Bone Marrow Transplantation. The individuals were submitted to an evaluation in the first 24 hours of hospitalization. The length of stay variable was checked on the day of hospital discharge. Functional capacity was assessed through the 6MWT, the 30-second sit-to-stand test (TSL30) was performed to assess the indirect strength of the lower limbs, moreover was used Revised Piper Fatigue Scale and evaluation of the pulmonary function. Results: The sample consisted of thirty-five individuals (19 male; 54%). Fourteen patients achieved a 6MWT ≥80% predicted. The mean age of the sample was 45.5 ± 15.2 years, and BMI 27.4 ± 5.4 kg/m². Patients who completed a 6MWD below the predicted value showed significantly lower pulmonary function values for the variables PEF(%) (p=0.031), FEV1 (%) (p=0.033) and FEV1/FVC(%) (p=0.027) in relation to the group with better functional capacity. This group showed significantly higher values in the assessment of lower limb fatigue using the Borg scale pre (p=0.008) and post (p=0.004) 6MWT, longer hospitalization time (p=0.0014), but with no significant difference in lower limb muscle strength between groups (p=0.21). A moderate correlation was found between the 6MWD% and FEV1% (p<0.05). Conclusion: Data indicate that starting HSCT treatment with lower-than-expected physical fitness is associated with lower lung function, greater fatigue in the lower limbs, and longer hospital stays.
- Open Access
- 25 June 2023
- Published by Atlântica Editora in Fisioterapia Brasil
- Vol. 24 (3) , 292-303
Função pulmonar, fadiga e qualidade de vida de pacientes oncológicos pediátricos
Objetivo: Avaliar a função pulmonar, a fadiga e a qualidade de vida de crianças e adolescentes diagnosticados com câncer e comparar os resultados entre os que estiveram em tratamento oncológico na internação com os que permaneceram em acompanhamento ambulatorial. Métodos: Estudo transversal incluindo pacientes oncológicos pediátricos (6-17 anos). Avaliada a função pulmonar com a espirometria, a fadiga e a qualidade de vida através do questionário Pediatric Quality of Life. Resultados: Foram avaliados 50 pacientes, 24 internados para tratamento oncológico e 26 em atendimento ambulatorial (cinco em fase de manutenção da quimioterapia e 15 em follow-up). A FP apresentou alteração em 26% dos pacientes, não havendo uma diferença significativa (p = 0,416) entre os internados (33,3%) e os ambulatoriais (19,2%), e nem para as variáveis de fadiga. Pacientes internados não apresentaram diferença na QV em relação aos ambulatoriais (p = 0,309), mas os pais perceberam pior QV nos pacientes internados (p = 0,046). Foi encontrada uma concordância moderada (r = 0,669) entre as percepções dos pais (escore 67,65 ± 16,06) e pacientes (escore 74,47 ± 15,42) quanto à QV. Na análise da fadiga não foi encontrada concordância entre as percepções de pais e pacientes (r = 0,353), pois eles perceberam-se melhores. Conclusão: Pacientes oncológicos pediátricos não apresentaram uma alteração significativa de FP, fadiga e QV, embora quando internados para tratamento, demonstraram uma pior QV que os acompanhados em ambulatório na percepção de seus pais.
- 25 June 2023
- Published by Atlântica Editora in Fisioterapia Brasil
- Vol. 24 (3) , 292-303
Open AccessFunção pulmonar, fadiga e qualidade de vida de pacientes oncológicos pediátricos
Objetivo: Avaliar a função pulmonar, a fadiga e a qualidade de vida de crianças e adolescentes diagnosticados com câncer e comparar os resultados entre os que estiveram em tratamento oncológico na internação com os que permaneceram em acompanhamento ambulatorial. Métodos: Estudo transversal incluindo pacientes oncológicos pediátricos (6-17 anos). Avaliada a função pulmonar com a espirometria, a fadiga e a qualidade de vida através do questionário Pediatric Quality of Life. Resultados: Foram avaliados 50 pacientes, 24 internados para tratamento oncológico e 26 em atendimento ambulatorial (cinco em fase de manutenção da quimioterapia e 15 em follow-up). A FP apresentou alteração em 26% dos pacientes, não havendo uma diferença significativa (p = 0,416) entre os internados (33,3%) e os ambulatoriais (19,2%), e nem para as variáveis de fadiga. Pacientes internados não apresentaram diferença na QV em relação aos ambulatoriais (p = 0,309), mas os pais perceberam pior QV nos pacientes internados (p = 0,046). Foi encontrada uma concordância moderada (r = 0,669) entre as percepções dos pais (escore 67,65 ± 16,06) e pacientes (escore 74,47 ± 15,42) quanto à QV. Na análise da fadiga não foi encontrada concordância entre as percepções de pais e pacientes (r = 0,353), pois eles perceberam-se melhores. Conclusão: Pacientes oncológicos pediátricos não apresentaram uma alteração significativa de FP, fadiga e QV, embora quando internados para tratamento, demonstraram uma pior QV que os acompanhados em ambulatório na percepção de seus pais.
- 23 January 2023
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (2) , 1-14
Physical rehabilitation for the management of cancer-related fatigue during cytotoxic treatment: a systematic review with meta-analysis
Objective To assess the effect of physical therapy on cancer-related fatigue (CRF) during cytotoxic anticancer treatment. Methods Systematic review with meta-analysis of randomized clinical trials published from 2010 to 2021 (EMBASE, MEDLINE, PEDro; SciELO, and LILACS). Studies assessing the effect of supervised physical therapy (IG) for the management of CRF on adults undergoing anticancer treatment compared with a control group (CG) covering usual care or any uncontrolled practice, such as recommendations about exercise and health education, were included in this review. Results A total of 22 studies were included in the SR and 21 in the meta-analysis, resulting in 1.992 individuals (CG = 973 and IG = 1.019). There was a reduction in general fatigue [SMD = − 0.69; 95%CI (− 1.15, − 0.22) p < 0.01; I2 = 87%; NNT = 3], with greater weight attributed to combined exercise (44%). Physical fatigue also reduced [SMD = − 0.76; 95%CI (− 1.13, − 0.39) p < 0.01; I2 = 90%; NNT = 2], with greater weight for resistance exercise (50%) and greater effect with combined exercise [SMD = − 1.90; 95%CI (− 3.04, − 0.76) p < 0.01; I 2 = 96%]. There was reduction in general fatigue with moderate intensity (74%) [SMD = − 0.89; 95%CI (− 1.61, − 0.17) p < 0.02; I2 = 90%] and physical fatigue [SMD = − 1.00; 95%CI (− 1.54, − 0.46) p < 0.01; I2 = 92%], while high intensity reduced only general fatigue [SMD = − 0.35; 95%CI (− 0.51, − 0.20) p < 0.01; I2 = 0%]. The number of overall and weekly sessions has been shown to contribute to the reduction of CRF. Conclusion Physical rehabilitation with moderate intensity promoted greater relief of general and physical fatigue. Even after controlling for high heterogeneity, the quality of evidence, summarized in GRADE, was considered moderate for general fatigue and low for physical fatigue.
- 23 January 2023
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (2) , 1-14
Physical rehabilitation for the management of cancer-related fatigue during cytotoxic treatment: a systematic review with meta-analysis
Objective To assess the effect of physical therapy on cancer-related fatigue (CRF) during cytotoxic anticancer treatment. Methods Systematic review with meta-analysis of randomized clinical trials published from 2010 to 2021 (EMBASE, MEDLINE, PEDro; SciELO, and LILACS). Studies assessing the effect of supervised physical therapy (IG) for the management of CRF on adults undergoing anticancer treatment compared with a control group (CG) covering usual care or any uncontrolled practice, such as recommendations about exercise and health education, were included in this review. Results A total of 22 studies were included in the SR and 21 in the meta-analysis, resulting in 1.992 individuals (CG = 973 and IG = 1.019). There was a reduction in general fatigue [SMD = − 0.69; 95%CI (− 1.15, − 0.22) p < 0.01; I2 = 87%; NNT = 3], with greater weight attributed to combined exercise (44%). Physical fatigue also reduced [SMD = − 0.76; 95%CI (− 1.13, − 0.39) p < 0.01; I2 = 90%; NNT = 2], with greater weight for resistance exercise (50%) and greater effect with combined exercise [SMD = − 1.90; 95%CI (− 3.04, − 0.76) p < 0.01; I 2 = 96%]. There was reduction in general fatigue with moderate intensity (74%) [SMD = − 0.89; 95%CI (− 1.61, − 0.17) p < 0.02; I2 = 90%] and physical fatigue [SMD = − 1.00; 95%CI (− 1.54, − 0.46) p < 0.01; I2 = 92%], while high intensity reduced only general fatigue [SMD = − 0.35; 95%CI (− 0.51, − 0.20) p < 0.01; I2 = 0%]. The number of overall and weekly sessions has been shown to contribute to the reduction of CRF. Conclusion Physical rehabilitation with moderate intensity promoted greater relief of general and physical fatigue. Even after controlling for high heterogeneity, the quality of evidence, summarized in GRADE, was considered moderate for general fatigue and low for physical fatigue.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 40
Evaluation of the functional capacity and quality of life of children and adolescents during and after cancer treatment
Objective: To evaluate the functional capacity and quality of life of children and adolescents during cancer treatment and post-treatment. Methods: Cross-sectional study of patients during cancer treatment and post-treatment, assessed by the 6-minute walk test (6MWT) and the Pediatric Quality of Life ™ questionnaire (cancer module). Results: Sixty-five patients, aged 11.2±3.5 years, mostly males (50.8%) and white (90.8%), with high incidence of hematological cancers (81.5%) participated in the study. The performance in the 6MWT was 23.1% inferior comparing the mean predicted and achieved (584.3±5 and 447.7±78.6 m, respectively). The percentage difference between the predicted and achieved 6MWT, and the different phases of cancer treatment were significantly different between patients in treatment (73.7±12.8) and post-treatment (84.5±9.1). When grouped by the different diagnoses, it was possible to observe that the distance covered by the patients with leukemia showed results closer to that predicted (80.7±11.7). Regarding the health-related quality of life questionnaire (HRQL), the child’s perception (78.0±14.56) was better than that reported by their parents (72.4±17.74). However, when we compared HRQL with the 6MWT, there was no association between them (p=0.597). Conclusions: Children and adolescents undergoing cancer treatment or post-treatment showed a 23% deficit in functional capacity. In relation to HRQL results, children’s perception was higher than that of their parents.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 40
Open AccessEvaluation of the functional capacity and quality of life of children and adolescents during and after cancer treatment
Objective: To evaluate the functional capacity and quality of life of children and adolescents during cancer treatment and post-treatment. Methods: Cross-sectional study of patients during cancer treatment and post-treatment, assessed by the 6-minute walk test (6MWT) and the Pediatric Quality of Life ™ questionnaire (cancer module). Results: Sixty-five patients, aged 11.2±3.5 years, mostly males (50.8%) and white (90.8%), with high incidence of hematological cancers (81.5%) participated in the study. The performance in the 6MWT was 23.1% inferior comparing the mean predicted and achieved (584.3±5 and 447.7±78.6 m, respectively). The percentage difference between the predicted and achieved 6MWT, and the different phases of cancer treatment were significantly different between patients in treatment (73.7±12.8) and post-treatment (84.5±9.1). When grouped by the different diagnoses, it was possible to observe that the distance covered by the patients with leukemia showed results closer to that predicted (80.7±11.7). Regarding the health-related quality of life questionnaire (HRQL), the child’s perception (78.0±14.56) was better than that reported by their parents (72.4±17.74). However, when we compared HRQL with the 6MWT, there was no association between them (p=0.597). Conclusions: Children and adolescents undergoing cancer treatment or post-treatment showed a 23% deficit in functional capacity. In relation to HRQL results, children’s perception was higher than that of their parents.
- Open Access
- 1 April 2021
- Published by Wolters Kluwer Health in Hematology/Oncology and Stem Cell Therapy
- Vol. 14 (2) , 126-133
Functional capacity, lung function, and muscle strength in patients undergoing hematopoietic stem cell transplantation
Objective/Background: Hematopoietic stem cell transplantation (HSCT) is a treatment for benign and malignant hematological diseases. These aggressive treatments cause reduced levels of physical activity, decreased lung function, and worse quality of life. Alterations in pulmonary function tests before HSCT are associated with the risk of respiratory failure and early mortality. The objective of this study was to evaluate functional capacity and lung function before and after HSCT and identify the predictors of mortality after 2 years. Methods: A prospective cohort study was carried out with individuals with oncohematological diseases. The evaluations were carried out in two moments during hospitalization and at hospital discharge. Follow-up was carried out after 48 months. Assessments were carried out on 34 adults, using spirometry, manovacuometry, 6-Minute Walk Test (6MWT), Handgrip Strength Test, and 30-Second Chair Stand Test (30-s CST). Results: There was a statistically significant reduction for the variables in forced vital capacity, forced expiratory volume predicted in the 1st second, Tiffeneau index, handgrip strength, and distance covered (% predicted) on the 6MWT (p < .05). There was a significant difference in the 30-s CST when individuals were compared according to the type of transplant. We found that a 10% reduction in the values of maximum inspiratory pressure (MIP) can predict an increased risk for mortality. Conclusions: Individuals undergoing HSCT have reduced functional capacity, lung function, and muscle strength during the hospitalization phase. Reduction in the values of MIP increases the risk of nonrelapse mortality.
- 1 April 2021
- Published by Wolters Kluwer Health in Hematology/Oncology and Stem Cell Therapy
- Vol. 14 (2) , 126-133
Open AccessFunctional capacity, lung function, and muscle strength in patients undergoing hematopoietic stem cell transplantation
Objective/Background: Hematopoietic stem cell transplantation (HSCT) is a treatment for benign and malignant hematological diseases. These aggressive treatments cause reduced levels of physical activity, decreased lung function, and worse quality of life. Alterations in pulmonary function tests before HSCT are associated with the risk of respiratory failure and early mortality. The objective of this study was to evaluate functional capacity and lung function before and after HSCT and identify the predictors of mortality after 2 years. Methods: A prospective cohort study was carried out with individuals with oncohematological diseases. The evaluations were carried out in two moments during hospitalization and at hospital discharge. Follow-up was carried out after 48 months. Assessments were carried out on 34 adults, using spirometry, manovacuometry, 6-Minute Walk Test (6MWT), Handgrip Strength Test, and 30-Second Chair Stand Test (30-s CST). Results: There was a statistically significant reduction for the variables in forced vital capacity, forced expiratory volume predicted in the 1st second, Tiffeneau index, handgrip strength, and distance covered (% predicted) on the 6MWT (p < .05). There was a significant difference in the 30-s CST when individuals were compared according to the type of transplant. We found that a 10% reduction in the values of maximum inspiratory pressure (MIP) can predict an increased risk for mortality. Conclusions: Individuals undergoing HSCT have reduced functional capacity, lung function, and muscle strength during the hospitalization phase. Reduction in the values of MIP increases the risk of nonrelapse mortality.
- 4 January 2021
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (7) , 4015-4021
Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors
Objective Hematopoietic stem cell transplantation (HSCT) is used as a treatment for several diseases. The objective was to evaluate the functional capacity, pulmonary function, and quality of life (QoL) in HSCT survivors. Methods The patients were submitted to spirometry and six-minute walk test (6MWT) and evaluation of QoL (Functional Assessment of Cancer Therapy Bone Marrow Transplantation—FACT-BMT) and the level of physical activity (Human Activity Profile—HAP) in the post-HSCT outpatient ambulatory. Results The sample was composed of 103 individuals with a mean age of 42.1 ± 12 and a median HSCT time of 5 (2–11) years. The average distance walked in the 6MWT was 524.7 ± 73.5 m; the FACT-BMT score, 82 ± 8.7 points; FEV1, 76.8 ± 22.6%; and HAP, 71.9 ± 11.2 points. There was a significant difference between debilitated and physically active individuals for the variables: forced expiratory volume in the first second (FEV1) in liters (p = 0.008) and % of predicted (p = 0.017), FEV1/FVC (p = 0.032), distance on the 6MWT (p < 0.001), fatigue after the 6MWT (p < 0.001), and physical well-being (p = 0.005). Conclusions HSCT survivors have long-term changes in functional capacity, pulmonary function, and QoL. Subjects more active had better results in pulmonary function and functional capacity.
- 4 January 2021
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (7) , 4015-4021
Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors
Objective Hematopoietic stem cell transplantation (HSCT) is used as a treatment for several diseases. The objective was to evaluate the functional capacity, pulmonary function, and quality of life (QoL) in HSCT survivors. Methods The patients were submitted to spirometry and six-minute walk test (6MWT) and evaluation of QoL (Functional Assessment of Cancer Therapy Bone Marrow Transplantation—FACT-BMT) and the level of physical activity (Human Activity Profile—HAP) in the post-HSCT outpatient ambulatory. Results The sample was composed of 103 individuals with a mean age of 42.1 ± 12 and a median HSCT time of 5 (2–11) years. The average distance walked in the 6MWT was 524.7 ± 73.5 m; the FACT-BMT score, 82 ± 8.7 points; FEV1, 76.8 ± 22.6%; and HAP, 71.9 ± 11.2 points. There was a significant difference between debilitated and physically active individuals for the variables: forced expiratory volume in the first second (FEV1) in liters (p = 0.008) and % of predicted (p = 0.017), FEV1/FVC (p = 0.032), distance on the 6MWT (p < 0.001), fatigue after the 6MWT (p < 0.001), and physical well-being (p = 0.005). Conclusions HSCT survivors have long-term changes in functional capacity, pulmonary function, and QoL. Subjects more active had better results in pulmonary function and functional capacity.